Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory S Thomas

Showing results (71-80 of 127) with videos related to

Pageof 13
Sort By:
JAMA Network Open|December 28, 2019
Atherosclerosis in 16th-Century Greenlandic Inuit MummiesL Samuel Wann, Jagat Narula, Ron Blankstein, et al.
JACC. Cardiovascular Imaging|March 18, 2019
Severe Bradycardia and Asystole Following Regadenoson in Pharmacological Myocardial Perfusion Imaging: Cases and Treatment RecommendationsLaith A Derbas, Gregory S Thomas, Crystal A Medina, et al.
Cancers|February 12, 2021
Genetic Analysis of Multiple Myeloma Identifies Cytogenetic Alterations Implicated in Disease Complexity and ProgressionCan Li, Erik B Wendlandt, Benjamin Darbro, et al.
Anatomical Record (Hoboken, N.J. : 2007)|May 23, 2015
The Tres Ventanas Mummies of PeruL Samuel Wann, Guido Lombardi, Bernadino Ojeda, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 8, 2014
Regadenoson provides perfusion results comparable to adenosine in heterogeneous patient populations: a quantitative analysis from the ADVANCE MPI trialsJohn J Mahmarian, Leif E Peterson, Jiaqiong Xu, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|February 23, 2017
The EXERRT trial: "EXErcise to Regadenoson in Recovery Trial": A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate exercise stress test as compared to regadenoson without exercise for myocardial perfusion imaging using a SPECT protocolGregory S Thomas, S James Cullom, Therese M Kitt, et al.
Journal of the American College of Cardiology|January 23, 2004
Technetium 99m sestamibi myocardial perfusion imaging predicts clinical outcome in the community outpatient setting. The Nuclear Utility in the Community (NUC) StudyGregory S Thomas, Michael I Miyamoto, A Peter Morello, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|January 20, 2009
The RegEx trial: a randomized, double-blind, placebo- and active-controlled pilot study combining regadenoson, a selective A(2A) adenosine agonist, with low-level exercise, in patients undergoing myocardial perfusion imagingGregory S Thomas, Randall C Thompson, Michael I Miyamoto, et al.
JACC. Cardiovascular Imaging|August 15, 2009
Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trialJohn J Mahmarian, Manuel D Cerqueira, Ami E Iskandrian, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|September 6, 2012
Selective improvement in Seattle Heart Failure Model risk stratification using iodine-123 meta-iodobenzylguanidine imagingEric S Ketchum, Arnold F Jacobson, James H Caldwell, et al.
Pageof 13

Showing results (71-80 of 127) with videos related to

Sort By:
Pageof 13
JAMA Network Open|December 28, 2019
Atherosclerosis in 16th-Century Greenlandic Inuit MummiesL Samuel Wann, Jagat Narula, Ron Blankstein, et al.
JACC. Cardiovascular Imaging|March 18, 2019
Severe Bradycardia and Asystole Following Regadenoson in Pharmacological Myocardial Perfusion Imaging: Cases and Treatment RecommendationsLaith A Derbas, Gregory S Thomas, Crystal A Medina, et al.
Cancers|February 12, 2021
Genetic Analysis of Multiple Myeloma Identifies Cytogenetic Alterations Implicated in Disease Complexity and ProgressionCan Li, Erik B Wendlandt, Benjamin Darbro, et al.
Anatomical Record (Hoboken, N.J. : 2007)|May 23, 2015
The Tres Ventanas Mummies of PeruL Samuel Wann, Guido Lombardi, Bernadino Ojeda, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|October 8, 2014
Regadenoson provides perfusion results comparable to adenosine in heterogeneous patient populations: a quantitative analysis from the ADVANCE MPI trialsJohn J Mahmarian, Leif E Peterson, Jiaqiong Xu, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|February 23, 2017
The EXERRT trial: "EXErcise to Regadenoson in Recovery Trial": A phase 3b, open-label, parallel group, randomized, multicenter study to assess regadenoson administration following an inadequate exercise stress test as compared to regadenoson without exercise for myocardial perfusion imaging using a SPECT protocolGregory S Thomas, S James Cullom, Therese M Kitt, et al.
Journal of the American College of Cardiology|January 23, 2004
Technetium 99m sestamibi myocardial perfusion imaging predicts clinical outcome in the community outpatient setting. The Nuclear Utility in the Community (NUC) StudyGregory S Thomas, Michael I Miyamoto, A Peter Morello, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|January 20, 2009
The RegEx trial: a randomized, double-blind, placebo- and active-controlled pilot study combining regadenoson, a selective A(2A) adenosine agonist, with low-level exercise, in patients undergoing myocardial perfusion imagingGregory S Thomas, Randall C Thompson, Michael I Miyamoto, et al.
JACC. Cardiovascular Imaging|August 15, 2009
Regadenoson induces comparable left ventricular perfusion defects as adenosine: a quantitative analysis from the ADVANCE MPI 2 trialJohn J Mahmarian, Manuel D Cerqueira, Ami E Iskandrian, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|September 6, 2012
Selective improvement in Seattle Heart Failure Model risk stratification using iodine-123 meta-iodobenzylguanidine imagingEric S Ketchum, Arnold F Jacobson, James H Caldwell, et al.
Pageof 13